vaccine, rotavirus




Agencia Lei Va Hong
Concise Prescribing Info
Live, oral pentavalent rotavirus vaccine
Prevention of rotavirus gastroenteritis in infants & childn caused by serotypes G1, G2, G3, G4 & G9.
Dosage/Direction for Use
Oral Vaccination series: 3 doses. Administer 1st dose at 6-12 wk of age & subsequent doses at 4- to 10-wk intervals. 3rd dose should not be given after 32 wk of age.
May be taken with or without food: Gently squeeze liqd into infant's mouth towards inner cheek until dosing tube is empty.
Hypersensitivity. Severe combined immunodeficiency disease (SCID).
Special Precautions
Individuals w/ malignancies or who are otherwise immunocompromised; those receiving immunosuppressive therapy; HIV-infected individuals; those who received blood transfusion or blood products including Ig w/in 42 days. Risk of transmission of vaccine virus strains to non-vaccinated contacts. Administer w/ caution to individuals w/ immunodeficient close contacts. Use w/ caution infants w/ active GI illness, chronic diarrhea or growth retardation, or a history of congenital abdominal disorders or intussusception. Follow-up on any symptoms suggestive of intussusception (severe abdominal pain or distress, persistent vomiting, bloody stools, abdominal bloating &/or high fever). Delay vaccination in case of acute infection or febrile illness. Not indicated for use in adults. Infant <6 wk.
Adverse Reactions
Diarrhea, vomiting; pyrexia. Anaphylactic reactions; urticaria, angioedema; gastroenteritis w/ vaccine viral shedding in infants w/ SCID, intussusception.
MIMS Class
Vaccines, Antisera & Immunologicals
ATC Classification
J07BH02 - rota virus, pentavalent, live, reassorted ; Belongs to the class of rota virus diarrhea vaccines.
RotaTeq vaccine (oral)
(pre-filled dosing tube) 2 mL x 1's
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Sign up for free
Already a member? Sign in